Absci (ABSI) Other Non-Current Assets (2020 - 2026)
Absci's (ABSI) quarterly Other Non-Current Assets came in at $383000.0 in Q1 2026, down 63.66% year-on-year from $1.1 million in Q1 2025, and down 63.63% quarter-over-quarter from $1.1 million in Q4 2025.
Absci (ABSI) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Absci has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $383000.0 for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $383000.0, down 63.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $383000.0 (down 63.66% YoY), and the FY2025 annual result was $1.1 million, changed 0.09% from the prior year.
- Other Non-Current Assets came in at $383000.0 for Q1 2026 at Absci, down from $1.1 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $16.5 million in Q2 2024 to a low of $383000.0 in Q1 2026.
- The 5-year median for Other Non-Current Assets is $1.3 million (2022), against an average of $6.3 million.
- Across the five-year window, Other Non-Current Assets jumped 1338.89% in 2024 and slumped 93.34% in 2025, its largest moves.
- Absci's Other Non-Current Assets stood at $15.0 million in 2022, then sank by 92.6% to $1.1 million in 2023, then retreated by 5.22% to $1.1 million in 2024, then dropped by 0.09% to $1.1 million in 2025, then plunged by 63.63% to $383000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $383000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 383,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 383,000.00 |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 16.21 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 15.80 Mn |
| Jun 30, 2024 | 16.51 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 15.07 Mn |
| Mar 31, 2023 | 15.03 Mn |
| Dec 31, 2022 | 15.02 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Jun 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | 1.84 Mn |
| Dec 31, 2021 | 16.84 Mn |
| Sep 30, 2021 | 10.51 Mn |
| Jun 30, 2021 | 10.50 Mn |